Not an SEC registrant

Synedgen, INC.

Customers

2 federal agencies

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$1.9M

FY2025 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 2

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $4.2M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Defense Defense Health Agency	$2.3M	FY 2024	1		HT942524C0049
SBIR PHASE III PROPOSAL NO. JW230017 TITLED, "OPTIMIZED, FIELD-STABLE GLYCOPOLYMER-MIMICKING POLYSACCHARIDE TO PREVENT MORBIDITY AND MORTALITY IN EXPOSURE TO IONIZING RADIATION OR NUCLEAR INJURY" Award HT942524C0049 on USAspending.gov ↗ Largest of 1 awards in FY2024: $2.3M obligated
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	$1.9M	FY 2025	1	$16.9M → $1.9M	75A50124C00047
ADVANCE THE DEVELOPMENT OF PAAG17G (DRUG PRODUCT: MIIST305), A ONCE DAILY, ORALLY ADMINISTERED, GUT-RESTRICTED DRUG, TO REDUCE MORTALITY AND MORBIDITY ARISING FROM ACUTE EXPOSURE TO IONIZING RADIATION, SPECIFICALLY GASTROINTESTINAL (GI) INJURY (GI-AR Award 75A50124C00047 on USAspending.gov ↗ Largest of 1 awards in FY2025: $1.9M obligated

Alerts are coming

Get an email when Synedgen, INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.